1. Programme
    2. Scientific programme


    Scientific programme


  •  
  • Detailed scientific program

  • Programme

    14.00 - 15.00

    Keynote lecture
    Elana Fertig    , Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, USA
    Forecasting pancreatic carcinogenesis

    15.00 - 18.30

    Session 1: Artificial Intelligence & Cancer

    • 15.00 - 15.40 : Alfonso Valencia, Barcelona Supercomputing Center, Barcelone, Spain
    • 15.40 - 15.55 : Selected communications
    • 15.55 - 16.15 : Ahmad Berjaoui, Technological research institute Saint Exupéry, Toulouse, France
                Using AI to better understand and treat glioblastoma
    • 16.15 - 17.15 : Coffee break, poster session and visit of exhibition
    • 17.15 - 17.35 : Camille Franchet, Toulouse University Cancer Institute-Oncopole, France 
                AI in pathology: from bias mitigation to models interpretability 
    • 17.35 - 17.50 : Selected communications
    • 17.50 - 18.30 : Andrei Zinovyev, EVOTEC, Toulouse, France
                 Complex and simple AI/ML models for harnessing molecular data in oncology 

    18.30 - 20.30

    Ice-breaking event, poster session, exhibition

    08.30 - 12.10

    Session 2:  Microenvironment and resistance 
     

    • 08.30 - 09.10 : Alexandra Naba, Department of Physiology and Biophysics at the University of Illinois, Chicago, USA
                 The extracellular matrix: from proteomic exploration to matritherapies
    • 09.10 - 09.25 : Selected Communications
    • 09.25 - 09.45 : Frédéric Lagarrigue, Institute of Pharmacology and Structural Biology, Toulouse, France
                Tumor-associated myeloid cells: Harnessing integrins to disrupt their contribution to cancer progression
    • 09.45 - 10.45 : Coffee break and poster session
    • 10.15 - 10.35 : Christel Devaud, Cancer Research Center of Toulouse, France
                 Harnessing gut immunity to target metastases
    • 10.35 - 10.50 : Selected Communications
    • 10.50 - 11.30 : Jean-Philippe Girard, Institute of Pharmacology and Structural Biology, Toulouse, France
                 High endothelial venules (HEVs): specialized blood vessels for lymphocyte entry in tumors during cancer immunity and immunotherapy
    • 11.30 - 12.10 : Fanny Mann, Marseille Developmental Biology Institute (IBDM), Marseille, France

    12.10 - 13.00

    Companies and technologies pitches

    13.00 - 14.30

    Lunch time and Poster session

    14.30 - 17.25

    Session 3:  Cancer therapeutic innovations
     

    • 14.30 - 15.10 : Miriam Martini, Molecular Biotechnology Center, University of Torino, Italy
                 Glutamine sensing in pancreatic cancer: from mechanisms of action to therapeutic perspectives
    • 15.10 - 15.25 : Selected Communications
    • 15.25 - 15.45 : Céline Gongora, Cancer Research Institute of Montpellier, Montpellier, France
                 Oxaliplatin, ATR inhibitor and anti-PD1 combinaison leads to colon cancer eradication through immune system activation
    • 15.45 - 16.15 : Coffee break and poster session
    • 16.15 - 16.35 : Olivier Calvayrac, Cancer Research Center of Toulouse, Toulouse, France
                 Deciphering non-genetic tumor adaptation to prevent resistance to targeted therapies in oncogene-addicted lung cancer
    • 16.35 - 16.50 : Selected Communications
    • 16.50 - 17.30 : Thomas Helleday, Karolinska Institutet, Stockholm, Sweden 
                From PARP to targeting MTHFD1/2 for cancer-specific folate trapping
    • 17.30 - 18.10 : Fabrice Barlesi, Gustave Roussy Insitute, Paris, France
                Challenges in oncology: the Gustave Roussy perspective

    20.30 - 00.00

    Gala Dinner

    09.00 - 12.00

    Session 4 : Molecular mechanisms of resistance
     

    • 08.30 - 09.10 : Sarah McClelland, Barts Cancer Institute, London, UK
                 Mechanisms of Genome Evolution in Cancer
    • 09.10 - 09.25 : Selected Communication
    • 09.25 - 09.45 : Fabian Erdel, Center for Integrative Biology, Toulouse, France
    • 09.45 - 10.15 : Sharma Priyanka, Institute of Pharmacology and Structural Biology, Toulouse, France
                Impact of Arginine Citrullination on Transcriptional Control in Cancer
    • 10.15 - 10.35 : Coffee break and poster session
    • 10.35 - 10.50 : Selected Communication
    • 10.50 - 11.30 : Gaëlle Legube, Center for Integrative Biology, Toulouse, France
    • 11.30 - 12.10 : Elsa Bernard, Gustave Roussy Insitute, Paris, France
                Clonal Hematopoiesis in Cancer
     

    12.10 - 12.50  

    Closing Keynote
    Geneviève Almouzni,     Institut Curie, Paris, France
    Histone variants and their partners shaping chromatin and cell fate.

    12.50

    Closure

  • PCO agency - partner of the event :
    INSIGHT OUTSIDE
    Project holder :
    GIP IUCT
    1 Av. Irène Joliot-Curie
    31100 Toulouse
    (*) Prices starting from fixed line incumbent, a surcharge may be applied by operators, counting the second after the first 45 seconds.

    According to France's Personal Data Privacy Act in effect since June 2004, you may send a request in writing to INSIGHT OUTSIDE 26 Avenue Jean Kuntzmann 38330 Montbonnot-Saint-Martin / France, or by email webmaster@insight-outside.fr to access your file in order to consult, modify and/or delete your personal information.

    © 2005 - 2024 Insight Outside

    Organisation congrès scientifique Toulouse